In a few cases, T790M appears as a primary EGFR mutation in NSCLC (de novo T790M) and leads to unfavorable treatment responses to first- and second-generation EGFR-TKIs [7]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.